Clavis Pharma ASA

Clavis Pharma ASA Oslo, Norway, 2 June 2008

Clavis Pharma ASA Clavis Pharma ASA (OSE: CLAVIS) will present results from the Phase I part of its Phase I/II study with ELACYT, within haematological cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting 2008, to be held in Chicago on 30 May to 3 June. The poster will be presented from 2:00PM to 6:00PM (CDT) on 1 June 2008 and includes updated results from all 77 patients treated in the study.

Clavis Pharma ASA Oslo, Norway, 28 May 2008